Skip to content

An evaluation of CapnostreamTM for contribution to the safety in patients undergoing sedation for endoscopy

An evaluation of CapnostreamTM for contribution to the safety in patients undergoing sedation for endoscopy - The utility of CapnostreamTM in patients undergoing sedation for endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026467
Enrollment
100
Registered
2017-03-10
Start date
2014-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatobiliary disease

Interventions

None listed

Sponsors

Department of Gastroenterology, Kinan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with the necessity of pancreatobiliary endoscopy 2.Patients who is American Society of Anesthesiologists physical status I-III 3. Patients who participated oneself with enough understanding after receiving enough explanation

Exclusion criteria

Exclusion criteria: 1. Patients who is American Society of Anesthesiologists physical status 4 or 5 2. Patients who is unable to give informed consent 3. Patients required monitored anesthesia care sedation 4. Patients used oxygen or noninvasive ventilation devices before the procedure 5. patients who had allergies to midazolam

Design outcomes

Primary

MeasureTime frame
Integrated pulmonary indexTM calculated with CapnostreamTM in patients undergoing sedation for pancreatobiliary endoscopy.

Secondary

MeasureTime frame
1.Comparison and association between Integrated pulmonary indexTM and oxygen saturation. 2.Comparison and association between Integrated pulmonary indexTM and end-tidal carbon dioxide. 3.Comparison and association between Integrated pulmonary indexTM and respiratory rate. 4.The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of Integrated pulmonary indexTM for respiratory depression. 5.Adverse events during this study.

Countries

Japan

Contacts

Public ContactHirofumi Yamanishi

Kinan Hospital Gastroenterology

hiroyamanishi0925@gmail.com0739-22-5000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026